MSD CUBIST HOLDINGS UNLIMITED COMPANY

MSD Cubist Holdings Unlimited Company is a global pharmaceutical organisation with a heritage of more than 130 years in developing medicines and vaccines that bring hope to patients worldwide. The company focuses on advancing a highly diverse pipeline of innovative therapies, ranging from macrocyclic peptides and antibody-drug conjugates to AI-driven drug discovery, with the aim of delivering meaningful impact for those who depend on its treatments.

Through its business development and licensing activities, MSD Cubist partners with early-stage innovators and clinical-stage programmes, helping to translate cutting-edge science into life-changing medicines. The firm also runs extensive clinical-trial programmes, collaborating with researchers and healthcare providers to answer tough scientific questions and bring new treatments to market. Sustainability is embedded in its daily operations, ensuring a safe and healthy future for people and communities across the globe.